ArticleNature communications2026

Targeting leucine-rich repeat kinase 2 overcomes resistance to oncolytic herpes simplex virus-based therapies in glioblastoma.

Yaning Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.